WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 17.46 HKD 0.46% Market Closed
Market Cap: 72.5B HKD
Have any thoughts about
WuXi Biologics (Cayman) Inc?
Write Note

Income Statement

Earnings Waterfall
WuXi Biologics (Cayman) Inc

Revenue
17.1B CNY
Cost of Revenue
-10.5B CNY
Gross Profit
6.6B CNY
Operating Expenses
-2.8B CNY
Operating Income
3.9B CNY
Other Expenses
-1.2B CNY
Net Income
2.6B CNY

Income Statement
WuXi Biologics (Cayman) Inc

Rotate your device to view
Income Statement
Currency: CNY
Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
1 619
N/A
2 019
+25%
2 534
+26%
3 087
+22%
3 984
+29%
4 321
+8%
5 612
+30%
8 075
+44%
10 290
+27%
13 090
+27%
15 269
+17%
16 554
+8%
17 034
+3%
17 116
+0%
Gross Profit
Cost of Revenue
(958)
(1 208)
(1 517)
(1 813)
(2 325)
(2 546)
(3 079)
(4 033)
(5 461)
(7 144)
(8 545)
(9 683)
(10 206)
(10 499)
Gross Profit
661
N/A
811
+23%
1 018
+25%
1 274
+25%
1 659
+30%
1 775
+7%
2 533
+43%
4 042
+60%
4 829
+19%
5 945
+23%
6 724
+13%
6 871
+2%
6 828
-1%
6 617
-3%
Operating Income
Operating Expenses
(222)
(282)
(321)
(368)
(597)
(655)
(888)
(1 128)
(1 520)
(1 719)
(2 166)
(2 493)
(2 681)
(2 763)
Selling, General & Administrative
(175)
(214)
(270)
(344)
(451)
(523)
(727)
(1 015)
(1 157)
(1 274)
(1 691)
(1 950)
(2 109)
(2 379)
Research & Development
(74)
(94)
(169)
(222)
(260)
(275)
(304)
(295)
(502)
(657)
(683)
(753)
(786)
(788)
Other Operating Expenses
28
27
118
198
114
144
143
181
139
212
208
210
214
404
Operating Income
439
N/A
529
+21%
697
+32%
906
+30%
1 062
+17%
1 120
+5%
1 645
+47%
2 914
+77%
3 309
+14%
4 226
+28%
4 558
+8%
4 378
-4%
4 147
-5%
3 855
-7%
Pre-Tax Income
Interest Income Expense
(119)
(37)
97
100
65
250
321
405
694
639
810
591
91
44
Non-Reccuring Items
(16)
(20)
(56)
(41)
0
(51)
0
0
0
0
0
(7)
(54)
(234)
Total Other Income
0
0
0
0
0
0
0
0
(10)
0
(10)
(5)
(11)
(11)
Pre-Tax Income
304
N/A
473
+56%
738
+56%
965
+31%
1 127
+17%
1 320
+17%
1 966
+49%
3 319
+69%
3 993
+20%
4 865
+22%
5 358
+10%
4 957
-7%
4 174
-16%
3 653
-12%
Net Income
Tax Provision
(51)
(63)
(107)
(134)
(116)
(28)
(273)
(474)
(485)
(618)
(808)
(690)
(603)
(640)
Income from Continuing Operations
253
410
630
830
1 010
1 292
1 693
2 845
3 509
4 247
4 550
4 267
3 571
3 013
Income to Minority Interest
0
0
0
1
3
8
(4)
(50)
(120)
(166)
(130)
(115)
(171)
(381)
Net Income (Common)
253
N/A
410
+62%
631
+54%
831
+32%
1 014
+22%
1 300
+28%
1 689
+30%
2 795
+65%
3 388
+21%
4 081
+20%
4 420
+8%
4 152
-6%
3 400
-18%
2 632
-23%
EPS (Diluted)
0.07
N/A
0.1
+43%
0.16
+60%
0.21
+31%
0.25
+19%
0.32
+28%
0.4
+25%
0.64
+60%
0.77
+20%
0.93
+21%
1.01
+9%
0.95
-6%
0.78
-18%
0.61
-22%

See Also

Discover More